In response to questions at yesterday's Senate Estimates hearing, officials said the previous challenge with recommending oral contraceptives at a viable price was the fault of companies for failing to include quality-of-life data in their submissions. …
Officials blame companies for not highlighting quality of life benefits
February 26, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Rare Cancers welcomes future funding for 'game-changing' cancer service
February 27, 2025 - - Latest News -
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 - - Latest News -
HTA go-slow on newborn screening leaves parents waiting and waiting
February 27, 2025 - - Latest News -
Officials blame companies for not highlighting quality of life benefits
February 26, 2025 - - Latest News -
US FDA accepts application for Telix's Zircaix and grants priority review
February 26, 2025 - - Australian Biotech -
Arovella receives commitments for $15 million following cancellation of January placement
February 26, 2025 - - Australian Biotech -
MTPConnect refreshes board with new appointment and retirement
February 26, 2025 -